KV1.3 THERAPEUTICS
Kv1.3 Therapeutics is a clinical stage biopharmaceutical company focused on advancing new treatment options for rare autoimmune diseases. Their initial focus is on the use of their novel Kv1.3 inhibitor, dalazatide, for the treatment of inclusion body myositis (IBM), a rare, progressively debilitating disease of the muscle.
KV1.3 THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.kv13therapeutics.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Levolta Pharmaceuticals
Levolta Pharmaceuticals is an innovative, clinical-stage pharmaceutical company
NeuroHealing Pharmaceuticals
NeuroHealing Pharmaceuticals Inc., a clinical stage biopharmaceutical company.
NeuroproteXeon
NeuroproteXeon is a clinical-stage pharmaceutical and drug delivery device company.
NovaRx
NovaRx Corporation is a clinical-stage biopharmaceutical company.
Se-cure Pharmaceuticals
Se-cure is a clinical stage & revenues generating, research-driven pharmaceutical company.
Current Employees Featured
Official Site Inspections
http://www.kv13therapeutics.com
- Host name: kv13therapeutics.com
- IP address: 192.227.145.134
- Location: Buffalo United States
- Latitude: 42.8864
- Longitude: -78.8781
- Metro Code: 514
- Timezone: America/New_York
- Postal: 14202
